Perrigo | PRGO - Ebitda


Perrigo reported $141.6M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Abbott USD 2.43B 844M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Corcept Therapeutics USD -49M 53.2M Mar/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
J&J USD 8.27B 1.08B Mar/2026
Merck USD -1.54B 7.84B Mar/2026
Nestle CHF 8.85B 239M Jun/2026
Pacira USD 48.67M 8.43M Jun/2026
Perrigo USD 141.6M 1.34B Mar/2026
Pfizer USD 6.01B 18M Jun/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Reckitt Benckiser GBP 1.95B 708M Jun/2025
Sanofi EUR 3.69B 375M Jun/2026
Supernus Pharmaceuticals USD 31.6M 2.37M Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026
Xeris Pharmaceuticals USD 12.33M 12.76M Mar/2026
Zoetis USD 939M 101M Dec/2025